Barclays Reiterates Overweight Rating for Assura (LON:AGR)

Barclays reiterated their overweight rating on shares of Assura (LON:AGRFree Report) in a research report report published on Friday morning, reports. They currently have a GBX 53 ($0.67) target price on the real estate investment trust’s stock.

Several other equities analysts have also recently commented on AGR. Berenberg Bank boosted their target price on Assura from GBX 49 ($0.62) to GBX 51 ($0.64) and gave the stock a buy rating in a research report on Monday, November 20th. Shore Capital assumed coverage on Assura in a report on Thursday, November 16th. They issued a buy rating on the stock. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to, Assura has a consensus rating of Moderate Buy and a consensus target price of GBX 56.25 ($0.71).

Check Out Our Latest Stock Report on AGR

Assura Stock Down 0.5 %

AGR stock opened at GBX 43 ($0.54) on Friday. The company has a current ratio of 1.29, a quick ratio of 2.84 and a debt-to-equity ratio of 82.21. The firm has a market capitalization of £1.28 billion, a PE ratio of -720.00, a PEG ratio of 3.60 and a beta of 0.30. Assura has a 1-year low of GBX 38.38 ($0.48) and a 1-year high of GBX 54.60 ($0.69). The business’s 50 day simple moving average is GBX 45.64 and its 200 day simple moving average is GBX 44.62.

Assura Dividend Announcement

The business also recently declared a dividend, which was paid on Wednesday, January 10th. Investors of record on Thursday, December 7th were given a GBX 0.82 ($0.01) dividend. The ex-dividend date was Thursday, December 7th. This represents a yield of 1.79%. Assura’s dividend payout ratio (DPR) is presently -5,000.00%.

Insider Buying and Selling at Assura

In other Assura news, insider Jayne Cottam purchased 728 shares of Assura stock in a transaction on Tuesday, December 5th. The shares were bought at an average price of GBX 45 ($0.57) per share, with a total value of £327.60 ($413.74). Over the last three months, insiders have acquired 1,397 shares of company stock worth $62,811. 0.24% of the stock is owned by company insiders.

About Assura

(Get Free Report)

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK – caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.

See Also

Analyst Recommendations for Assura (LON:AGR)

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with's FREE daily email newsletter.